NEW YORK (GenomeWeb) – Congenica announced today that it has raised £8 million ($10 million) after closing a round of Series B financing.

The British genomics company will use the proceeds from the round to invest in sales and marketing efforts for its Sapientia clinical genome analysis platform, as well as for R&D.